← Directory

Medios AI

Remidio

CE markeddiabetic retinopathy

Offline deep-learning algorithm that runs on a smartphone-based fundus camera to flag referable diabetic retinopathy within seconds.

Company
Remidio
Category
Screening
Reads
Fundus images from the Remidio NM-FOP smartphone-based camera
Built for
Community and primary-care screening outside the US
Billing
Check vendor
Regulatory
CE mark under EU MDR Class II announced Feb 23, 2023; also approved by Singapore HSA. Press coverage states it is not FDA-approved and not sold in the US. · source
Last verified
2026-10-07

DotAEye is independent of Remidio. Confirm indications, intended use, and clearance status with the manufacturer before clinical use.